Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
263.00    -4.00 (-1.50%)
Bid:
261.00
Ask:
264.00
Spread: 3.00 (1.149%)
Market Cap: £236.40m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

CORRECTION: Publication of Prospectus

16 Nov 2009 10:41

RNS Number : 5539C
Norcros PLC
16 November 2009
 



THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR THEIR RESPECTIVE TERRITORIES OR ANY OTHER EXCLUDED TERRITORY. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

This release replaces the announcement "Publication of Prospectus" which was published at 07:04, 16 November 2009. The following amends have been made:

 

The date 12 November has replaced "yesterday" in regard to the Norcros announcement in the first paragraph.

The date 13 November has been inserted in reference to the prospectus announcement date in the first and second paragraph.

Norcros plc

("Norcros" or "the Company")

PUBLICATION OF PROSPECTUS

Further to the announcement by Norcros plc on 12 November in relation to a Capital Raising to raise gross proceeds of approximately £30 million, Norcros plc announces that a prospectus dated 13 November (the "Prospectus") relating to the proposed Firm Placing of 285,766,932 New Ordinary Shares at 7 pence per New Ordinary Share and Placing and Open Offer of 142,804,496 New Ordinary Shares at 7 pence per New Ordinary Share, which includes a notice convening a general meeting, has been approved by the UK Listing Authority and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at 25 The North Colonnade, Canary Wharf, London E14 5HS. 

Copies of the Prospectus were posted on 13 November to Shareholders and will also be available shortly on the Group's website (www.norcros.com). The Prospectus can also be inspected at the offices of the Company at Ladyfield House, Station Road, Wilmslow, Cheshire SK9 1BU, England and at the offices of Addleshaw Goddard LLP at Milton Gate, 60 Chiswell Street, London EC1Y 4AGduring normal business hours on any weekday (except Saturdays, Sundays and public holidays).

Terms defined in the Prospectus have the same meanings in this announcement.

16 November 2009

Norcros plc

Tel: 01625 547700

Joe Matthews, Group Chief Executive

Nick Kelsall, Group Finance Director

Oriel

Tel: 020 7710 7600

Emma Ormond

David Arch

Jonathan Walker

College Hill

Tel: 020 7457 2020

Mark Garraway

Adam Aljewicz

Important notice

This announcement has been issued by and is the sole responsibility of Norcros.

This announcement is an advertisement. It is not a prospectus and investors should not subscribe for or purchase any shares referred to in this announcement except on the basis of information contained in the Prospectus. The Prospectus, will be made available on Norcros' website and will be available for inspection at the UK Listing Authority's announcement viewing facility.

This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to acquire, any New Ordinary Shares, nor shall it (or any part of it), or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract or commitment whatsoever with respect to the proposed Firm Placing and Placing and Open Offer or otherwise.

The information in this announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Canada, Australia, Japan, or the Republic of South Africa or their respective territories or any other Excluded Territory The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933 (the "Securities Act"). The securities mentioned herein may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public or other offer of securities in the United States. 

The distribution of this announcement in certain jurisdictions may be restricted by law and such distribution could result in violation of the laws of such jurisdictions. In particular, this announcement is not for distribution in the Excluded Territories.

The information in this announcement may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. Any forwarding, distribution, reproduction or disclosure of this information in whole or in part is unauthorised. Failure to comply with this restriction may result in a violation of the Securities Act or the applicable laws of other jurisdictions.

Any person receiving this announcement is advised to exercise caution in relation to the Firm Placing and Placing and Open Offer. If in any doubt about any of the contents of this announcement, independent professional advice should be obtained.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIGUGWPGUPBGUQ
Date   Source Headline
21st May 20267:00 amRNS-RInvestor Presentation Webinar on 18 June 2026
12th May 20267:00 amRNSStrategic update: South African operations
30th Apr 202611:42 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSYear-end Trading and Board update
2nd Apr 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSBlock Listing Six Monthly Return
3rd Mar 20269:29 amRNSDirectors Share Dealing - correction
3rd Mar 20267:00 amRNSDirectors Share Dealing
2nd Feb 20267:00 amRNSAppointment of Joint Corporate Broker
14th Jan 202612:12 pmRNSDirectors Share Dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
28th Nov 20254:03 pmRNSHolding(s) in Company
20th Nov 20256:22 pmRNSDirectors Share Dealing
20th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNS-RInvestor Presentation Webinar on 1 December 2025
21st Oct 20255:04 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSTrading update
13th Oct 20257:24 amRNSCompletion of Acquisition of Fibo Holding AS
30th Sep 202511:46 amRNSBlock Listing Six Monthly Return
23rd Jul 202512:03 pmRNSDirector Dealings - APSP and DBP Share Options
23rd Jul 202511:59 amRNSResults of AGM
23rd Jul 20257:11 amRNSAGM Trading Statement
21st Jul 20254:11 pmRNSDirector Dealings - DBP Share Option exercises
16th Jul 20255:01 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSAcquisition of Fibo Holding AS
23rd Jun 20257:00 amRNSJTSA Outcome of Strategic Review
20th Jun 20254:10 pmRNSAnnual Financial Report and Notice of 2025 AGM
12th Jun 20257:00 amRNSResults for the year ended 31 March 2025
3rd Jun 20257:00 amRNS-RInvestor Webinar
10th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
31st Mar 20257:00 amRNSBlock Listing 6 Monthly Return
31st Mar 20257:00 amRNSTotal Voting Rights
13th Mar 20257:00 amRNSPension Scheme Valuation Update
5th Feb 20253:45 pmRNSDirectors Share Dealing
31st Dec 20247:00 amRNSVoting Rights and Share Capital Update
10th Dec 202411:49 amRNSHolding(s) in Company
6th Dec 202411:52 amRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSTotal Voting Rights
21st Nov 20245:01 pmRNSHolding(s) in Company
21st Nov 202411:57 amRNSInterim Results - Replacement
21st Nov 20247:00 amRNSResults for the six months ended 30 September 2024
1st Nov 20247:00 amRNSTotal Voting Rights
10th Oct 20247:00 amRNSTrading update
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 202410:08 amRNSBlock listing Six Monthly Return
30th Aug 20247:00 amRNSTotal Voting Rights
24th Jul 20241:50 pmRNSResults of AGM
24th Jul 20241:24 pmRNSDirector Dealings - APSP Share Option Awards
24th Jul 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.